New visitor? Consider subscribing by RSS or by email.
This month’s Institutional Investor magazine has an interesting article on Matt Feshbach. Now head of MLF Investments, Feshbach is known for co-founding Feshbach Brothers, an aggressive trading firm that was synonymous with short-selling in the 1980s.
Feshbach is now [...]
You can tell a lot about an institutional buyer’s conviction based on how they accumulate shares. If they buy as the price dips, they are often just averaging down a bad trade. But large purchases following a price increase show that the institution expects great things from the company.
Take a look at Highland [...]
Advocat (AVCA) and Todd Robinson, who is waging a proxy contest for three seats on Advocat’s board, each tried to garner public support today. The company suggested that Robinson’s goal is to push through a related-party transaction:
Advocat Inc. (NASDAQ OTC: AVCA - News) urges its shareholders to vote their shares of stock at [...]
Investors’ struggle to maximize shareholder value at Advocat, Inc. (AVCA) just got a little more interesting. Today investors Todd Robinson and Essel Bailey, Jr. filed a definitive preliminary proxy seeking three board seats (for the two of them plus Terry Cash). Robinson was formerly CEO of Omega Wordlwide, parent of Omega Healthcare Investors, [...]